- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04817592
Characterization of the Corneal Biomechanics of Patients Treated by Corneal Lenticule Extraction for Advanced Refractive Correction (CLEAR) to Correct Myopia (CLEAR Biomech)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Refractive surgery techniques such as laser in situ keratomileusis (LASIK), corneal lenticule extraction (SMILE/CLEAR) and photorefractive keratectomy (PRK) are becoming increasingly popular among myopic patients. With current surgical planning tools, there is a reported 10-15 % chance of over/under correction, in particular with higher corrections. The biggest factor that leads to this discrepancy is the "one size fits all" approach. Patient specific characteristics of the eye such as the corneal material properties, are not considered in the surgical planning. This information is also essential for diagnosis and treatment of pathologies like keratoconus. New diagnostics devices based on e. g. Brillouin scattering are now introduced on the market, with the aim to provide an in-vivo quantification of the biomechanical tissue properties. However, the relationship between the Brillouin measurement and the biomechanical properties of the cornea is not fully understood yet. The investigators aim for determining an improved relationship between the optical Brillouin measurement performed in-vivo preoperatively and classical destructive biomechanical testing of the extracted corneal lenticule after the surgery. This lenticule is currently discarded after surgery.
The purpose of the study is to investigate the exact relationship between the classically determined material properties (by stress-/strain measurements) and optically obtained data by Brillouin scattering, which are collected during pre-op investigations. A precise characterization and relation between both measurements will allow clinicians to better predict surgical parameters and perform better refractive interventions. This information will also inform clinicians on the mechanical status of the cornea of patients suffering from subclinical keratoconus.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Philippe Büchler, Prof. Dr.
- Phone Number: +41 31 684 14 10
- Email: philippe.buechler@unibe.ch
Study Locations
-
-
-
Zurich, Switzerland, 8002
- IROC AG
-
Contact:
- Theo Seiler, Priv.-Doz. Dr. med.
- Email: theo@seiler.tv
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduled for CLEAR procedures for myopia (range: >-3D with an astigmatism <0.25D) in the age group 20-50 years.
- Willing and able to return for scheduled follow-up examinations
- Able to provide written informed consent and follow study instructions in English or German
Exclusion Criteria:
- Irregular corneal topo-/tomography (Asymmetry >1.0D within the inner 5mm)
- Previous intraocular or corneal surgery of any kind in the eye to be treated, including any type of surgery for either refractive or therapeutic purposes.
- History of steroid-responsive rise in intraocular pressure, glaucoma, or preoperative intraocular pressure (IOP) > 21 mmHg in either eye.
- History of diabetes, diagnosed autoimmune disease, connective tissue disease or clinically significant atopic syndrome.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Age1(20-25)
The groups are divided as per age
|
Routinely conducted procedure for correction of Myopia
Other Names:
|
|
Age2(25-30)
|
Routinely conducted procedure for correction of Myopia
Other Names:
|
|
Age3(30-35)
|
Routinely conducted procedure for correction of Myopia
Other Names:
|
|
Age4(35-40)
|
Routinely conducted procedure for correction of Myopia
Other Names:
|
|
Age5(40-45)
|
Routinely conducted procedure for correction of Myopia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biomechanics of extracted lenticule
Time Frame: 1 year
|
During the CLEAR intervention, the lenticule extracted will be marked for physiological direction to identify the nasal-temporal and superior-inferior directions and stored at room temperature in normal culture medium from eye banking with 6% dextran.
The mechanical experiments on these lenticules, will be performed within 24hours after extraction to preserve the sample properties.
The samples will undergo uniaxial tensile testing in IROC using the UStretch (Cellscale, Waterloo, ON, Canada) device.
Post tensile testing, the samples will be imaged using Second-harmonic imaging microscopy (SHG microscopy).
SHG microscopy will be used to determine the in-plane probability distribution describing the orientation and density of the collagen fibrils present in the CLEAR lenticules.
This information will be incorporated into a computational model which will simulate the uniaxial stress-strain measurements to further help us identify the parameters of a non-linear constitutive material model.
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philippe Büchler, Prof. Dr., University of Bern
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Basec Nr 2021-001-45
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on Corneal lenticule extraction for advanced refractive correction (CLEAR)
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Singapore Eye Research InstituteRecruiting